{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:00:37Z","timestamp":1790290837912,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jsbmb.2012.02.007","type":"journal-article","created":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T11:01:54Z","timestamp":1331204514000},"page":"80-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome"],"prefix":"10.1016","volume":"132","author":[{"given":"Annamaria","family":"Morelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Comeglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Sarchielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cellai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Vignozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravit","family":"Yehiely-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Maneschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Gacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Carini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Adorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella B.","family":"Vannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2012.02.007_bib0005","first-page":"1213","article-title":"Benign prostatic hyperplasia","volume":"15","author":"Webber","year":"2006","journal-title":"Clin. Evid."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0010","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1152\/physrev.00038.2003","article-title":"Urinary bladder contraction and relaxation: physiology and pathophysiology","volume":"84","author":"Andersson","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0015","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.eururo.2004.12.013","article-title":"Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)","volume":"47","author":"Rosen","year":"2005","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0020","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.juro.2006.07.030","article-title":"Long-term physical activity and lower urinary tract symptoms in men","volume":"176","author":"Orsini","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1464-410X.2005.05571.x","article-title":"Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health And Nutrition Examination Survey","volume":"96","author":"Rohrmann","year":"2005","journal-title":"BJU Int."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.juro.2007.03.103","article-title":"Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems","volume":"178","author":"Parson","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MOU.0b013e3283336f3f","article-title":"Lower urinary tract symptoms, obesity and the metabolic syndrome","volume":"20","author":"Moul","year":"2010","journal-title":"Curr. Opin. Urol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0040","first-page":"157","article-title":"Metabolic syndrome and urologic diseases","volume":"12","author":"Gorbachinsky","year":"2010","journal-title":"Rev. Urol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0045","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.urology.2007.01.011","article-title":"Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III)","volume":"69","author":"Rohrmann","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1439-0272.2008.00880.x","article-title":"Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men","volume":"41","author":"Haider","year":"2009","journal-title":"Andrologia"},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2605.2008.00951.x","article-title":"Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases","volume":"32","author":"Corona","year":"2009","journal-title":"Int. J. Androl."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0060","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrendo.2009.212","article-title":"Testosterone deficiency, insulin resistance and the metabolic syndrome","volume":"5","author":"Zitzmann","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0065","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.amjmed.2010.12.027","article-title":"Testosterone deficiency","volume":"124","author":"Traish","year":"2011","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0070","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1743-6109.2010.01991.x","article-title":"Testosterone and metabolic syndrome: a meta-analysis study","volume":"8","author":"Corona","year":"2011","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0075","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1464-410X.2007.07069.x","article-title":"An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat","volume":"100","author":"Rahman","year":"2007","journal-title":"BJU Int."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0080","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/S0022-5347(05)68995-1","article-title":"Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit","volume":"161","author":"Azadzoi","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0085","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2353\/ajpath.2008.070594","article-title":"Development of diabesity in mice with neuronal deletion of Shp2 tyrosine phosphatase","volume":"172","author":"Krajewska","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0090","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1111\/j.1743-6109.2009.01467.x","article-title":"Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome","volume":"6","author":"Filippi","year":"2009","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/JOE-11-0289","article-title":"Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit","volume":"212","author":"Vignozzi","year":"2012","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1743-6109.2010.02073.x","article-title":"Farnesoid X receptor activation improves erectile function in animal models of metabolic syndrome and diabetes","volume":"8","author":"Vignozzi","year":"2011","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0110","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1210\/en.2002-220384","article-title":"Estrogens but not androgens regulate expression and functional activity of oxytocin receptor in rabbit epididymis","volume":"143","author":"Filippi","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0115","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/jm025529g","article-title":"6-Alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity","volume":"45","author":"Pellicciari","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0120","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1124\/mol.110.064501","article-title":"Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist","volume":"78","author":"Rizzo","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/pros.20463","article-title":"B.X.L-628 a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA\/Rho kinase signaling in rat and human bladder","volume":"67","author":"Morelli","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1743-6109.2006.00208.x","article-title":"Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat","volume":"3","author":"Vignozzi","year":"2006","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1743-6109.2009.01558.x","article-title":"Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats","volume":"7","author":"Morelli","year":"2010","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0140","first-page":"97","article-title":"Simultaneous analysis of famiglie of sigmoidal curves: application to biomass, radioligand assay, and physiological dose response curves","volume":"235","author":"De Lean","year":"1978","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0145","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1007\/s00018-005-5370-2","article-title":"Lactoferrin: a modulator of immune and inflammatory responses","volume":"62","author":"Legrand","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0150","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1073\/pnas.0810473106","article-title":"Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with of prostate cancer","volume":"106","author":"Sfanos","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0155","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0160","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bbadis.2010.10.013","article-title":"Farnesoid X receptor activation improves erectile dysfunction in models of metabolic syndrome and diabetes","volume":"1812","author":"Morelli","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0165","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.eururo.2011.06.037","article-title":"Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"60","author":"Gacci","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0170","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.juro.2008.01.086","article-title":"Bladder dysfunction in rats with metabolic syndrome induced by long-term fructose feeding","volume":"179","author":"Lee","year":"2008","journal-title":"J. Urol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0175","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.eururo.2006.01.031","article-title":"The association between vascular risk factors and lower urinary tract symptoms in both sexes","volume":"50","author":"Ponholzer","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0180","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0022-5347(01)66471-1","article-title":"Direct measurement of blood flow in the human bladder","volume":"155","author":"Batista","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1464-410X.1998.0820s1026.x","article-title":"Age-related erectile and voiding dysfunction: the role of arterial insufficiency","volume":"82","author":"Tarcan","year":"1998","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0190","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.eururo.2005.02.001","article-title":"Erectile dysfunction and lower urinary tract symptoms secondary to BPH","volume":"47","author":"McVary","year":"2005","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0195","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.lfs.2007.05.004","article-title":"Effects of doxazosin on blood flow and mRNA expression of nitric oxide synthase in the spontaneously hypertensive rat genitourinary tract","volume":"81","author":"Yono","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0200","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0895-4356(01)00351-1","article-title":"Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men","volume":"54","author":"Meigs","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0205","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.juro.2009.04.025","article-title":"Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey","volume":"182","author":"Kupelian","year":"2009","journal-title":"J. Urol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0210","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMra0910283","article-title":"Hypoxia and inflammation","volume":"364","author":"Eltzschig","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0215","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/nau.20999","article-title":"Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action","volume":"30","author":"Andersson","year":"2011","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0220","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2605.2009.00972.x","article-title":"Chronic inflammation in the pathogenesis of benign prostatic hyperplasia","volume":"33","author":"Fibbi","year":"2010","journal-title":"Int. J. Androl."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0225","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2741\/3812","article-title":"Inflammatory markers and cardiovascular risk in the metabolic syndrome","volume":"16","author":"Espinola-Klein","year":"2011","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0230","first-page":"507","article-title":"Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention Korean","volume":"52","author":"Abdollah","year":"2011","journal-title":"J. Urol."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/cvr\/cvm016","article-title":"FXR-mediated regulation of eNOS expression in vascular endothelial cells","volume":"77","author":"Li","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jsbmb.2012.02.007_bib0240","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1743-6109.2007.00440.x","article-title":"Testosterone regulates RhoA\/Rho-kinase signaling in two distinct animal models of chemical diabetes","volume":"4","author":"Vignozzi","year":"2007","journal-title":"J. Sex. Med."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076012000490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076012000490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:39:58Z","timestamp":1760744398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076012000490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":48,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0960076012000490"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2012.02.007","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2012.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}